• About & Contact Us
  • SEO Community

Ulancer.com

    • Latest Stories

      What is new?

    • Meet the startups that pitched at EF’s 10th Demo Day in London

      September 27, 2018

    • Rally Rd., the app that lets you invest in classic cars, raises $7M Series A

      September 27, 2018

  • News
  • How to’s
  • Writing
  • Startups
  • Jobs
  • More
    • CMS Tools
    • APPS
    • Web Resources
      • Advertising
      • Firefox
      • Scripts
      • Tools

Life sciences startup Avro aims to deliver drugs to children and the elderly through skin patches

  • by Ulancer Contributor
  • In Startups
  • — 19 Feb, 2018


Avro, a life sciences startup in Y Combinator’s current batch, is banking on a method to deliver medications to populations unable to swallow or chew — it will administer them through the skin.

Starting with allergy medications, the startup is developing skin patches that release drugs commonly used in seasonal allergies for children. The patches act much like nicotine patches, which deliver nicotine to those trying to quit smoking, but can deliver a variety of drugs, such as allergy medications, through our body’s largest organ.

Co-founder Shakir Lakhani, who suffers from both seasonal and food allergies himself, tells TechCrunch he wanted to start with allergy relief not just for personal reasons but because it’s an area where children are resistant to taking the medications already out there.

“There’s medications that say they taste like banana but don’t really taste like banana, ” he said. “The drugs are also relatively safe so it’s something we can work with without being too worried.”

It’s also not the first company to offer transdermal drug delivery. Miami-based pharmaceutical company ProSolus creates skin patches for delivery of various generic drugs and over-the-counter products, Fremont outfit Zosano makes specialty transdermal patches for delivery of migraine-reducing medicines and Viaskin is making a patch for kids with peanut allergies — though clinical trials have so far not gone well.

These companies could easily start offering the same types of patches as Avro, should the startup prove the market need.

One advantage is that the drugs Avro wants to use in its patches are already out there — it wouldn’t need to prove they work. They just need to prove the delivery method is safe and effective.

But the startup has a long way to go before getting these patches into the hands of consumers. First, Avro will need FDA approval to sell in the United States and Canada, where the company plans to market its patches. To get there, it will need to conduct some human clinical trials, which Lakhani says he’s in the process of looking into at the moment but believes he’ll be able to get up and running in Q3 of this year.

Lakhani also mentioned his skin patches could eventually offer other types of medicines.

“We’re looking at things like people suffering from near degenerative diseases and more intense diseases that inhibit your ability to swallow, like Multiple Sclerosis,” he told TechCrunch. “I think those will be really interesting avenues for us to go down in the future and we’re just starting to initiate conversations with other companies who might be good partners for us.”


News source

You might also like...

  • Devialet is getting a new CEO 5 Mar, 2018
  • Certify acquires real-time expense management startup and YC alum Abacus 17 Jul, 2018
  • Cleveland offered $120 million in freebies lure Amazon to the city 11 May, 2018
  • The FDA is cracking down on Juul e-cig sales to minors 26 Apr, 2018
  • Previous story Combining augmented reality, 3D printing and a robotic arm to prototype in real time
  • Next story Update for iOS and Macs negates text bomb that crashed devices
  • RSS
    Receive Freebies & Latest Posts Directly To Your Email - it's Free!

    • Recent Posts
    • Most Popular
    • Comments
    • 7hrCggmJ-AMMeet the startups that pitched at EF’s 10th Demo Day in LondonSeptember 27, 2018
    • oNo38LV2tQIRally Rd., the app that lets you invest in classic cars, raises $7M Series ASeptember 27, 2018
    • Nearby.gifBerkanan is a Bluetooth-powered group messaging appSeptember 27, 2018
    • 2122.pngVinay Gupta to talk about Mattereum at Disrupt BerlinSeptember 27, 2018
    • slider_wp_03Best collection of WordPress Slider PluginsJuly 5, 2010
    • Joomla template builderTop 8 Free Joomla Template GeneratorsJuly 19, 2011
    • 40+ Best WordPress Plugins for Comments40+ Best WordPress Plugins for CommentsJune 18, 2011
    • wptheme2A Collection of Free WordPress ThemesJuly 11, 2010
    • Bharat Sarkari Naukri on:Spotify acquires online music studio Soundtrap as it goes after creators
    • PMP on:Online learning platform Unacademy gets $21M Series C from Sequoia India, SAIF and Nexus
    • Predictive Eye on:Element.AI opens London outpost with focus on ‘AI for good’
    • SmartCursors on:4 Tips for Keeping Your Freelance Finances In Order
  • Staff Picks

    • slider_wp_03Best collection of WordPress Slider PluginsJuly 5, 2010
    • Joomla template builderTop 8 Free Joomla Template GeneratorsJuly 19, 2011
    • 40+ Best WordPress Plugins for Comments40+ Best WordPress Plugins for CommentsJune 18, 2011
  • Recent Posts

    • Meet the startups that pitched at EF’s 10th Demo Day in London
    • Rally Rd., the app that lets you invest in classic cars, raises $7M Series A
  • Search Our Blog

  • Ulancer is an insightful freelance blog and resource site. We provide intuitive articles that cover Photoshop tutorials, time-saving management tips covering a broad range of topics. We also have an active freelance community forum, there you can meet other freelancers that share your common interest, socialize and chat about freelance trending news as the occurred.

© Copyright 2013 Ulancer.